Exploiting the neonatal crystallizable fragment receptor to treat kidney disease. Dylewski JF, Haddad G, Blaine J. Kidney Int 2024;105:54-64.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dylewski JF, Haddad G, Blaine J. Exploiting the neonatal crystallizable fragment receptor to treat kidney disease. Kidney Int 2024;105:54-64.
PMID: 38707675